Angiostatin potentiates cyclophosphamide treatment of metastatic disease

Cancer Chemotherapy and Pharmacology

Volumn 50, Issue 5, 2002, Pages 412-418

  Mauceri, Helena J ^a   Seetharam, Saraswathy ^a   Beckett, Michael A ^a   Schumm, L Philip ^b   Koons, Ann ^a   Gupta, Vinay K ^b   Park, James O ^b   Manan, Abdullah ^a   Lee, John Y ^a   Montag, Anthony G ^b   Kufe, Donald W ^c   Weichselbaum, Ralph R ^a  

^a MC 9006   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Angiostatin; Cyclophosphamide; Lewis lung carcinoma; Metastasis

Indexed keywords

ANGIOSTATIN; CYCLOPHOSPHAMIDE;

ANGIOGENESIS; ANIMAL MODEL; ARTICLE; CELL MIGRATION; CELL SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; DRUG INHIBITION; DRUG POTENTIATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LEWIS CARCINOMA; LUNG METASTASIS; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

ANGIOGENESIS INHIBITORS; ANGIOSTATINS; ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, LEWIS LUNG; CELL MOVEMENT; CELLS, CULTURED; CYCLOPHOSPHAMIDE; DRUG SCREENING ASSAYS, ANTITUMOR; DRUG SYNERGISM; ENDOTHELIUM, VASCULAR; HUMANS; LINEAR MODELS; LUNG NEOPLASMS; MICE; MICE, INBRED C57BL; MORPHOGENESIS; NEOPLASM METASTASIS; NEOVASCULARIZATION, PHYSIOLOGIC; PEPTIDE FRAGMENTS; PLASMINOGEN; PROTEIN SYNTHESIS INHIBITORS; SINGLE-BLIND METHOD; TUMOR CELLS, CULTURED;

EID: 0036450557     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-002-0514-7     Document Type: Article

References (26)

1. Folkman J (1990) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82:4-6
2. Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27-31
3. Folkman J, D'Amore PA (1996) Blood vessel formation: What is its molecular basis? Cell 87:1153-1155
4. Folkman J (1992) The role of angiogenesis in tumor growth. Semin Cancer Biol 3:89-96
5. Denekamp J (1993) Review article: Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy. Br J Radiol 66:181-196
6. Paweletz N, Knierim M (1989) Tumor-related angiogenesis. Crit Rev Oncol Hematol 9:197-242
7. Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353-364
8. Hanahan D, Christofori G, Naik P, Arbeit J (1996) Transgenic mouse models of tumour angiogenesis: The angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models. Eur J Cancer 32A:2386-2393
9. O'Reilly M, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J (1994) Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79:315-328
10. O'Reilly M, Holmgren L, Chen C, Folkman J (1996) Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med 2:689-692
11. Sim BK, MS OR, Liang H, Fortier AH, He W, Madsen JW, Lapcevich R, Nacy CA (1997) A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer. Cancer Res 57:1329-1334
12. Lannutti BJ, Gately ST, Quevedo ME, Soff GA, Paller AS (1997) Human angiostatin inhibits murine hemangioendothelioma tumor growth in vivo. Cancer Res 57:5277-5280
13. Kirsch M, Strasser J, Allende R, Bello L, Zhang J, Black PM (1998) Angiostatin suppresses malignant glioma growth in vivo. Cancer Res 58:4654-4659
14. Mauceri HJ, Hanna NN, Beckett MA, Gorski DH, Staba MJ, Stellato KA, Bigelow K, Heimann R, Gately S, Dhanabal M, Soff GA, Sukhatme VP, Kufe DW, Weichselbaum RR (1998) Combined effects of angiostatin and ionizing radiation in antitumour therapy. Nature 394:287-291
15. Gorski DH, Mauceri HJ, Salloum RM, Gately S, Hellman S, Beckett MA, Sukhatme VP, Soff GA, Kufe DW, Weichselbaum RR (1998) Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin. Cancer Res 58:5686-5689
16. Grant DS, Kinsella JL, Fridman R, Auerbach R, Piasecki BA, Yamada Y, Zain M, Kleinman HK (1992) Interaction of endothelial cells with a laminin A chain peptide (SIKVAV) in vitro and induction of angiogenic behavior in vivo. J Cell Physiol 153:614-625
17. Hallahan DE, Mauceri HJ, Seung LP, Dunphy EJ, Wayne JD, Hanna NN, Toledano A, Hellman S, Kufe DW, Weichselbaum RR (1995) Spatial and temporal control of gene therapy using ionizing radiation. Nat Med 1:786-791
18. McCullagh P, Nelder JA (1989) Generalized Linear Models. Chapman and Hall, New York
19. Liang KY, Zeger SL (1986) Longitudinal data analysis using generalized linear models. Biometrika 73:13-22
20. Ohira T, Ohe Y, Heike Y, Podack ER, Olsen KJ, Nishio K, Nishio M, Miyahara Y, Funayama Y, Ogasawara H, et al (1994) Gene therapy for Lewis lung carcinoma with tumor necrosis factor and interleukin 2 cDNAs co-transfected subline. Gene Ther 1:269-275
21. Teicher BA, Holden SA, Ara G, Korbut T, Menon K (1996) Comparison of several antiangiogenic regimens alone and with cytotoxic therapies in the Lewis lung carcinoma. Cancer Chemother Pharmacol 38:169-177
22. Ohizumi Y, Maezawa H, Mori T (1988) Time course of development of metastasis in irradiated Lewis lung carcinoma: Relationship between primary tumor volume and metastasis. Radiat Med 6:179-184
23. Kakeji Y, Teicher BA (1997) Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agents. Invest New Drugs 15:39-48
24. Teicher BA, Sotomayor EA, Huang ZD (1992) Antiangiogenic agents potentiate cytotoxic cancer therapies against primary and metastatic disease. Cancer Res 52:6702-6704
25. Hari D, Beckett MA, Sukhatme VP, Dhanabal M, Nodzenski E, Lu H, Mauceri HJ, Kufe DW, Weichselbaum RR (2000) Angiostatin induces mitotic cell death of proliferating endothelial cells. Mol Cell Biol Res Commun 3:277-282
26. Al-Mehdi AB, Tozawa K, Fisher AB, Shientag L, Lee A, Muschel RJ (2000) Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: A new model for metastasis. Nat Med 6:100-102